title: Sudden death of a patient in complete remission after anthracycline therapy for acute lymphoblastic leukemia.
authors.affiliation: Department of Pediatrics, Asahikawa Medical College, Hokkaido, Japan. Tsuda5p@asahikawa-med.ac.jp
authors.forename: N
authors.initials: N
authors.lastname: Tsuda
authors.forename: R
authors.initials: R
authors.lastname: Oka
authors.forename: H
authors.initials: H
authors.lastname: Kajino
authors.forename: M
authors.initials: M
authors.lastname: Kajino
authors.forename: A
authors.initials: A
authors.lastname: Okuno
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D002675:Child, Preschool; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004562:Electrocardiography; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012074:Remission Induction
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; C027260:pirarubicin